Relievant Medsystems is a commercial-stage medical device company transforming the diagnosis and treatment of vertebrogenic pain, a form of CLBP, with the Intracept Procedure- a novel, clinically proven and commercially available treatment designed to improve the quality of life for millions of indicated patients.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/20/23 | $50,000,000 | Series G |
Ally Bridge Group Canaan Partners Endeavor Vision Lightstone Ventures Morgenthaler New Enterprise Associates Vensana Capital | undisclosed |
